Clinical Trial Update: A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/Phase 2 study evaluating three doses of TCH346 in patients with early Parkinson's disease. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• TCH346 (TCH-346)

Snippet

Sponsor: Novartis | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: COMPLETED